packageLenograstim

lenograstim

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Lenograstim is a granulocyte colony-stimulating factor used to stimulate white blood cell production, mainly to treat or prevent neutropenia in patients receiving cancer chemotherapy. It is an approved medicine, authorised in the European Union, and used in clinical practice for chemotherapy-induced neutropenia and related conditions.

Summary written by glm-5.3-flash from Wikidata Q6523037 and the WHO ATC classification; not checked by a person.

name:lenograstim
ATC codes:L03AA10
DrugBank:DB13144
Wikidata:Q6523037

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown